Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor. Case report

Inhibition of endocytic processes by photodynamic therapy

On the purity and definition of oligomeric HPD formulations

Sites of photosensitization by protoporphyrin and tin protoporphyrin in leukemia L1210 cells

Comment on “A guide to the terminology of hematoporphyrincatalyzed photosensitization” (Michael A. J. Rodgers, J. Photochem. Photobiol., B. Biol., 5 (1990) 525) — a comment

Structural analysis of HPD

The role of low-density lipoprotein in the biodistribution of photosensitizing agents

Modes of photodynamic vs. sonodynamic cytotoxicity

Protein-binding patterns of the antitumor antibiotic cryptophycin 52 as measured with a two-phase partitioning system

Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients

Mitochondrial photodamage and PDT-induced apoptosis

Tumor versus vascular photodamage in a rat tumor model

Subcellular Localization of Photosensitizing Agents Introduction

The Role of Subcellular Localization in Initiation of Apoptosis by Photodynamic Therapy

Enhanced Responsiveness to Photodynamic Therapy-Induced Apoptosis after Mitochondrial DNA Depletion

Studies on the Subcellular Localization of the Porphycene CPO

Introduction to the Symposium–in–Print: Photodynamic Therapy

The Bcl-2 Antagonist HA14-1 Forms a Fluorescent Albumin Complex that Can Be Mistaken for Several Oxidized ROS Probes

Promotion of PDT Efficacy by a Bcl-2 Antagonist

Apoptosis and Autophagy After Mitochondrial or Endoplasmic Reticulum Photodamage